[Comments on retroperitoneal lymphadenectomy - laparoscopic versus robotic]

Area of Science:

• Uro-oncology
• Surgical oncology
• Germ cell tumors

Background:

• Retroperitoneal lymph node dissection (RPLND) has a limited role in managing high-risk clinical stage I nonseminomatous germ cell tumors (NSGCT).
• Chemotherapy regimens like PEB (cisplatin, etoposide, bleomycin) offer superior efficacy.
• RPLND may be considered for pure mature teratomas with adverse prognostic factors.

Purpose of the Study:

• To evaluate the role and techniques of RPLND in clinical stage I NSGCT.
• To compare open, laparoscopic, and robotic-assisted RPLND approaches.
• To assess the indications for post-chemotherapy RPLND (PC-RPLND).

Main Methods:

• Review of current literature and guidelines on RPLND for NSGCT.
• Analysis of surgical techniques including nerve-sparing and template-guided dissection.
• Comparison of outcomes for open, laparoscopic, and robotic-assisted procedures.

Main Results:

• Laparoscopic RPLND is inferior to open RPLND for clinical stage I NSGCT, often leading to adjuvant chemotherapy.
• Robotic-assisted RPLND for clinical stage I NSGCT is experimental with insufficient evidence.
• Open PC-RPLND is recommended for complex cases in tertiary centers; laparoscopic PC-RPLND is reserved for select cases.
• Evidence for robotic-assisted PC-RPLND is lacking.

Conclusions:

• RPLND for clinical stage I NSGCT is indicated only in rare, specific circumstances.
• Open RPLND, when performed, should utilize nerve-sparing and template-guided techniques.
• PC-RPLND remains an open surgical procedure for specialized centers, with limited roles for minimally invasive approaches.